Trimethoprim-sulfamethoxazole에 대해 지연성 과민반응을 보인 환자에서 성공적인 급속 탈감작 치료 사례 1예
Successful rapid desensitization to trimethoprim-sulfamethoxazole-induced delayed hypersensitivity
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Trimethoprim-sulfamethoxazole (TMP-SMX) is an antibiotic used for the treatment or prophylaxis of Pneumocystis pneumonia and other infectious conditions. Sulfonamide derivatives have been reported to cause delayed hypersensitivity reactions, resulting in switch to less effective second-line antibiotics. Although desensitization is traditionally known to be effective in patients with immediate hypersensitivity, it is also applied to the treatment of delayed hypersensitivity in recent years. A 66-year-old female who had a history of repeated TMP-SMX-induced delayed hypersensitivity presenting as whole body rashes needed to take prophylactic dose of TMP-SMX (80/400 mg daily) before initiation of chemotherapy for multiple myeloma. Intravenous rapid desensitization was performed by using a 11-step, 4-bottle protocol from 1:1,000 to 1:1 solution for 3 hours to reach the target dose for prophylaxis. After successful rapid desensitization of TMP-SMX, 1-month prophylaxis was completed without any complications until the patient recovered normal immunity. We herein reported a case of delayed hypersensitivity reaction to TMP-SMX in an about-to-be immunocompromised host with planned chemotherapy who successfully completed 1-month prophylaxis with the drug without any complications through rapid desensitization.
Abstract
Trimethoprim-sulfamethoxazole (TMP-SMX) is an antibiotic used for the treatment or prophylaxis of Pneumocystis pneumonia and other infectious conditions. Sulfonamide derivatives have been reported to cause delayed hypersensitivity reactions, resulting in switch to less effective second-line antibiotics. Although desensitization is traditionally known to be effective in patients with immediate hypersensitivity, it is also applied to the treatment of delayed hypersensitivity in recent years. A 66-year-old female who had a history of repeated TMP-SMX-induced delayed hypersensitivity presenting as whole body rashes needed to take prophylactic dose of TMP-SMX (80/400 mg daily) before initiation of chemotherapy for multiple myeloma. Intravenous rapid desensitization was performed by using a 11-step, 4-bottle protocol from 1:1,000 to 1:1 solution for 3 hours to reach the target dose for prophylaxis. After successful rapid desensitization of TMP-SMX, 1-month prophylaxis was completed without any complications until the patient recovered normal immunity. We herein reported a case of delayed hypersensitivity reaction to TMP-SMX in an about-to-be immunocompromised host with planned chemotherapy who successfully completed 1-month prophylaxis with the drug without any complications through rapid desensitization.
참고문헌 (11)
- Bang J, "Guidance of antibiotic therapy" (2008), MIP
- Pichler WJ, "Drug hypersensitivity" (2007), Karger
- Douglas R, "Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole", Clin Infect Dis, pp.1480~ (1997)
- Pyle RC, "Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction", J Allergy Clin Immunol Pract, 2, pp.52~58 (2014)
- Patriarca G, "Desensitization to co-trimoxazole in a patient with fixed drug eruption", J Investig Allergol Clin Immunol, 18, pp.309~311 (2008)
- 김명신, "말초 조혈모세포 이식 후 과민반응을 보인 환자의 사이클로스포린 탈감작", 천식 및 알레르기, 28(1), pp.59~63 (2008), 대한천식알레르기학회
- Yoshizawa S, "A 5-day course of oral desensitization to trimethoprim", sulfamethoxazole(T, S, pp.Ann Allergy Asthma Immunol, 2000[DOI]
- 이애라, "일차 항결핵제 모두에 과민반응을 보인 환자의 성공적 탈감작 결핵 치료 1예", Allergy Asthma & Respiratory Diseases, 1(4), pp.395~399 (2013), 대한 소아알레르기 호흡기학회
- Scherer K, "Desensitization in delayed drug hypersensitivity reactions : an EAACI position paper of the Drug Allergy Interest Group", Allergy, 68, pp.844~852 (2013)
- Millikan LE, "Immunology of adverse drug eruptions", Clin Dermatol, 4, pp.30~39 (1986)
- Castells M, "Hypersensitivity to antineoplastic agents : mechanisms and treatment with rapid desensitization", Cancer Immunol Immunother, 61, pp.1575~1584 (2012)